Hello I'm Raiyyan Tahsan
Brand Model and Executive

đŸŠē TC(1372).(09).Gynecology Department Case No (46):-Suspected Vulvovaginitis with Vaginal and Urethral Burning, Possible Bacterial Vaginosis / Trichomoniasis; R/O Cervicitis and Acute Cystitis, with Hand Paresthesia & H/O Cervical Erosion (1Prescription+0Report+0Image)2233

Prescription attached:-

LIPU MED — COMPLETE CLINICAL PRESCRIPTION REVIEW

Corrected Prescription | Evidence-Based Clinical Working Assessment | MedEx Bangladesh | CDC | NICE | Medical Textbooks

Author: Md.Rafiqul Islam Lipu

Original Prescription Date: 21 April 2025

Clinical Review Date: Thursday, 15 October 2026

āĻŦāĻžāĻ‚āϞāĻž āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟

āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏ, āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻŋ⧟āĻžāϏāĻŋāϏ, āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ‚ āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇ āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ Erosion āĻ“ D&C/ECC-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Diagnostic status: Provisional — āϰ⧋āĻ— āύāĻŋāĻļā§āϚāĻŋāϤ āĻšā§ŸāύāĻŋāĨ¤


Website-Verified Case Number

raiyyantahsan.com-āĻāϰ Medical Blog āĻāĻŦāĻ‚ Gynecology Archive āĻĒ⧁āύāϰāĻžā§Ÿ āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

Numbering Latest published New case
Total Case (TC) 1371 1372
Department Code 09 09
Gynecology Case Number 45 46

āϏāĻ°ā§āĻŦāĻļ⧇āώ āĻĒā§āϰāĻ•āĻžāĻļāĻŋāϤ TC(1371) Pediatric Case āĻāĻŦāĻ‚ Gynecology Case No.45 āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϛ⧇āĨ¤ āϤāĻžāχ āύāϤ⧁āύ āĻāχ āϕ⧇āϏ⧇āϰ āύāĻŽā§āĻŦāϰ TC(1372).(09).Gynecology Department Case No (46)āĨ¤

Confidence: 0.99


1. Patient Information — āϰ⧋āĻ—ā§€āϰ āϤāĻĨā§āϝ

Clinical parameter Prescription finding āĻŦāĻžāĻ‚āϞāĻž āĻŦā§āϝāĻžāĻ–ā§āϝāĻž Confidence
Sex Female āύāĻžāϰ⧀ āϰ⧋āĻ—ā§€ 0.99
Age Not clearly documented āĻŦ⧟āϏ āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟ 0.30
Prescription date 21/04/2025 ⧍⧧ āĻāĻĒā§āϰāĻŋāϞ ⧍ā§Ļ⧍ā§Ģ 0.95
Weight 81 kg āĻ“āϜāύ ā§Žā§§ āϕ⧇āϜāĻŋ 0.95
BP Approximately 100/80 mmHg āφāύ⧁āĻŽāĻžāύāĻŋāĻ• āϰāĻ•ā§āϤāϚāĻžāĻĒ ā§§ā§Ļā§Ļ/ā§Žā§Ļ 0.80
Obstetric history P3, NVD × 3 āϤāĻŋāύāϟāĻŋ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĒā§āϰāϏāĻŦ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ 0.90
Previous cervical procedure D&C/ECC āĻĒā§‚āĻ°ā§āĻŦ⧇ āϜāϰāĻžā§Ÿā§/āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇ curettage procedure 0.85
Laboratory report Not attached āϕ⧋āύ⧋ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āϰāĻŋāĻĒā§‹āĻ°ā§āϟ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§ŸāύāĻŋ 1.00

Clinical limitation: āϰ⧋āĻ—ā§€āϰ āĻŦ⧟āϏ, pregnancy status, allergies, pelvic examination āĻāĻŦāĻ‚ laboratory results āύāĻž āĻĨāĻžāĻ•āĻžā§Ÿ definitive infectious diagnosis āĻĻ⧇āĻ“ā§ŸāĻž āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤


2. C/C — Chief Complaints

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻĒā§āϰāϧāĻžāύ āĻ…āĻ­āĻŋāϝ⧋āĻ—āϗ⧁āϞ⧋ āύāĻŋāĻšā§‡ āϏāĻ‚āĻļā§‹āϧāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āĻšāϞ⧋āĨ¤

C/C 1 — Pain & Burning Sensation in Vagina and Urethra

English: Pain and burning sensation involving the vaginal and urethral region.

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϰ āφāĻļāĻĒāĻžāĻļ⧇ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻžāĨ¤

Clinical significance:

āĻāχ āωāĻĒāϏāĻ°ā§āĻ— āύāĻŋāĻŽā§āύ⧋āĻ•ā§āϤ āϰ⧋āϗ⧇ āĻšāϤ⧇ āĻĒāĻžāϰ⧇:

  • Vulvovaginitis — āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  • Bacterial Vaginosis — āϝ⧋āύāĻŋāϰ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝ⧇āϰ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύāĨ¤
  • Trichomoniasis — āĻĒā§āϰ⧋āĻŸā§‹āĻœā§‹ā§ŸāĻžāϜāύāĻŋāϤ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤
  • Vulvovaginal Candidiasis — āĻ›āĻ¤ā§āϰāĻžāĻ• āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤
  • Cystitis/Urethritis — āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋ āĻŦāĻž āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  • Cervicitis — āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  • Contact Vulvitis — āϏāĻžāĻŦāĻžāύ āĻŦāĻž āϰāĻžāϏāĻžā§ŸāύāĻŋāϕ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻœā§āĻŦāĻžāϞāĻžāĨ¤

Finding confidence: 0.98

C/C 2 — Numbness in Hand

English: Numbness in hand.

āĻŦāĻžāĻ‚āϞāĻž: āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻŦāĻž āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻ•āĻŽā§‡ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

āĻāϟāĻŋ āϏāĻŽā§āĻ­āĻŦāϤ āĻāĻ•āϟāĻŋ āĻĒ⧃āĻĨāĻ• neurological complaintāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāϪ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ°ā§Ÿā§‡āϛ⧇ peripheral nerve entrapment, vitamin B12 deficiency, diabetes-related neuropathy āĻ…āĻĨāĻŦāĻž cervical radiculopathyāĨ¤

āĻļ⧁āϧ⧁ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ⧇āϰ āĻ…āĻ­āĻŋāϝ⧋āĻ— āĻĨ⧇āϕ⧇ peripheral neuropathy āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

Finding confidence: 0.96

C/C 3 — Previous Gynecological Procedure

English: H/O D&C/ECC due to cervical erosion.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§‚āĻ°ā§āĻŦ⧇ Cervical Erosion-āĻāϰ āĻ•āĻžāϰāϪ⧇ D&C/ECC āĻ•āϰāĻž āĻšā§Ÿā§‡āĻ›āĻŋāϞ āĻŦāϞ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ procedure date: 01/03/2025āĨ¤

āϤāĻžāϰāĻŋāĻ– āĻāĻŦāĻ‚ procedure-āĻāϰ āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāĻŦāϰāĻŖ original records āĻĻāĻŋā§Ÿā§‡ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

Confidence: 0.82


3. Patient History — āϰ⧋āĻ—ā§€āϰ āχāϤāĻŋāĻšāĻžāϏ

A. M/H — Menstrual History

Parameter Doctor's note āĻŦāĻžāĻ‚āϞāĻž
LMP 10/04/2025 āĻļ⧇āώ āĻŽāĻžāϏāĻŋāϕ⧇āϰ āĻĒā§āϰāĻĨāĻŽ āĻĻāĻŋāύ ā§§ā§Ļ āĻāĻĒā§āϰāĻŋāϞ ⧍ā§Ļ⧍ā§Ģ
Menstrual period 6 days āĻŽāĻžāϏāĻŋāĻ• āĻ›ā§Ÿ āĻĻāĻŋāύ āĻ¸ā§āĻĨāĻžā§Ÿā§€ āĻšā§Ÿ
Menstrual cycle Regular āύāĻŋ⧟āĻŽāĻŋāϤ āĻŽāĻžāϏāĻŋāĻ•
Menstrual flow Average āĻŽāĻžāĻāĻžāϰāĻŋ āϰāĻ•ā§āϤāĻĒāĻžāϤ
Dysmenorrhoea Negative āĻŽāĻžāϏāĻŋāĻ•āĻ•āĻžāϞ⧀āύ āĻŦā§āϝāĻĨāĻžāϰ āĻ…āĻ­āĻŋāϝ⧋āĻ— āύ⧇āχ

Confidence: 0.92

Clinical Interpretation

āĻāχ menstrual history āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϰ⧋āĻ—ā§€āϰ cycle āύāĻŋ⧟āĻŽāĻŋāϤ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤ āϤāĻŦ⧇ cycle length, intermenstrual bleeding, postcoital bleeding āĻāĻŦāĻ‚ contraception history āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤


B. O/H — Obstetric History

Prescription note Interpretation āĻŦāĻžāĻ‚āϞāĻž
MF — 22 years Married for 22 years, likely āϏāĻŽā§āĻ­āĻŦāϤ āĻŦāĻŋāĻŦāĻžāĻšāĻŋāϤ āĻœā§€āĻŦāύ ⧍⧍ āĻŦāĻ›āϰ
P3 (NVD) +0 Three vaginal deliveries āϤāĻŋāύāϟāĻŋ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĒā§āϰāϏāĻŦ
ALC — 13 years Age of Last Child, likely āϏāĻŽā§āĻ­āĻŦāϤ āϏāĻ°ā§āĻŦāĻļ⧇āώ āϏāĻ¨ā§āϤāĻžāύ⧇āϰ āĻŦ⧟āϏ ā§§ā§Š āĻŦāĻ›āϰ

Confidence: 0.82

Important: Obstetric notation-āĻāϰ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻ…āĻ°ā§āĻĨ āĻŽā§‚āϞ āύāĻĨāĻŋ āĻĻāĻŋā§Ÿā§‡ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤


C. Past Gynecological History

H/O Cervical Erosion

Cervical Erosion / Cervical Ectropion — āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ EctropionāĨ¤

Cervical ectropion-āĻ endocervical glandular epithelium āĻŦāĻžāχāϰ⧇āϰ āĻĻāĻŋāϕ⧇ āĻĻ⧃āĻļā§āϝāĻŽāĻžāύ āĻšā§ŸāĨ¤

āĻāϟāĻŋ āϏāĻŦāϏāĻŽā§Ÿ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ, āĻ•ā§āώāϤ āĻ…āĻĨāĻŦāĻž āĻ•ā§āϝāĻžāύāϏāĻžāϰ⧇āϰ āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āύ⧟āĨ¤

H/O D&C/ECC

D&C — Dilation and Curettage

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžā§Ÿā§āϰ āĻŽā§āĻ– āĻĒā§āϰāϏāĻžāϰāĻŋāϤ āĻ•āϰ⧇ āϜāϰāĻžā§Ÿā§āϰ āϭ⧇āϤāϰ⧇āϰ āφāĻŦāϰāĻŖ āĻĨ⧇āϕ⧇ tissue āϏāĻ‚āĻ—ā§āϰāĻš āĻŦāĻž āĻ…āĻĒāϏāĻžāϰāĻŖāĨ¤

ECC — Endocervical Curettage

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ canal āĻĨ⧇āϕ⧇ tissue āϏāĻ‚āĻ—ā§āϰāĻšāĨ¤

Procedure-āĻāϰ indication āĻ“ histopathology report āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§ŸāύāĻŋāĨ¤

Confidence: 0.85


D. D/H — Drug History

Not documented — āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

āφāϗ⧇ antibiotic, antifungal, hormonal medicine āĻ…āĻĨāĻŦāĻž sedative āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰ⧇āϛ⧇āύ āĻ•āĻŋ āύāĻž āϜāĻžāύāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

E. Allergy History

Not documented — āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ macrolide āĻ“ nitroimidazole allergy āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϜāĻžāύāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

F. Family History

Not documented — āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

G. O/S/E — Other Systemic Examination

Neurological, cardiovascular, respiratory āĻāĻŦāĻ‚ abdominal examination-āĻāϰ āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāĻŦāϰāĻŖ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤


4. O/E — On Examination

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ:

Weight: 81 kg

Blood Pressure: Approximately 100/80 mmHg

Clinical Interpretation

Weight: Height āĻ›āĻžā§œāĻž BMI āύāĻŋāĻ°ā§āϪ⧟ āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤

Blood Pressure: āĻāĻ•āϟāĻŋ reading āĻĨ⧇āϕ⧇ hypotension āĻŦāĻž hypertension āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

O/G/E — Obstetric/Gynecological Examination

āύāĻŋāĻšā§‡āϰ findings āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝāĻ­āĻžāĻŦ⧇ documented āύ⧟:

Examination Finding
Vulval examination Not documented
Vaginal discharge assessment Not documented
Speculum examination Not documented
Cervical appearance Not documented
Cervical motion tenderness Not documented
Bimanual examination Not documented

Conclusion: āĻŦāĻ°ā§āϤāĻŽāĻžāύ cervical erosion, cervicitis āĻŦāĻž vaginal infection-āĻāϰ objective evidence āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

Confidence: 0.98


5. Doctor's Diagnosis, Investigation, Plan & Advice

A. Doctor's Documented Diagnosis

Current Dx: Not clearly written.

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Cervical Erosion āωāĻ˛ā§āϞ⧇āĻ– āĻĨāĻžāĻ•āϞ⧇āĻ“ āĻāϟāĻŋ āĻĒā§‚āĻ°ā§āĻŦ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āĻšāĻŋāϏ⧇āĻŦ⧇ āϞ⧇āĻ–āĻžāĨ¤

āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ BV, Trichomoniasis, Cervicitis, UTI āĻ…āĻĨāĻŦāĻž Candida infection āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟāĻ­āĻžāĻŦ⧇ diagnosis āĻ•āϰāĻž āĻšā§Ÿā§‡āĻ›ā§‡â€”āĻāĻŽāύ āϞ⧇āĻ–āĻž āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

Confidence: 0.95

B. Doctor's Investigations

No clearly documented investigations identified.

Urine R/E, Urine Culture, Vaginal Swab, CBC āĻ…āĻĨāĻŦāĻž āϕ⧋āύ⧋ laboratory result āύ⧇āχāĨ¤

C. Doctor's Plan

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϚāĻžāϰāϟāĻŋ āĻ“āώ⧁āϧ āĻĻāĻŋā§Ÿā§‡āϛ⧇āύāĨ¤ āϏāĻ‚āĻļā§‹āϧāĻŋāϤ medication schedule āĻĒāϰ⧇āϰ āĻ…āĻ‚āĻļ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āĻšāϞ⧋āĨ¤

D. Doctor's Advice

āĻ•āĻŋāϛ⧁ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ āĻšāĻžāϤ⧇ āϞ⧇āĻ–āĻž āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āϤāĻŦ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ investigation advice āĻŦāĻž follow-up instruction āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Clinical documentation confidence: 0.95


6. Corrected Prescription Transcription

✅ Table 1 — Verified Prescription Medicines

āφāĻĒāύāĻžāϰ āϏāĻ‚āĻļā§‹āϧāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϚāĻžāϰāϟāĻŋ āĻ“āώ⧁āϧ⧇āϰ āϏāĻ āĻŋāĻ• āύāĻžāĻŽ, strength, dose āĻāĻŦāĻ‚ duration:

No. Brand name Generic name Strength Dose Duration Total tablets
1 Xionil Bromazepam 3 mg 0+0+1 15 days 15
2 Zithrox Azithromycin Dihydrate 500 mg 0+0+1 7 days 7
3 Riboflavine Riboflavin (Vitamin B2) 5 mg 1+0+1 1 month 60 (assuming 30 days)
4 Ornil Ornidazole 500 mg 1+0+1 To be continued Not defined

Dose Interpretation

0+0+1: āϏāĻ•āĻžāϞ⧇ āύ⧟, āĻĻ⧁āĻĒ⧁āϰ⧇ āύ⧟, āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ tabletāĨ¤

1+0+1: āϏāĻ•āĻžāϞ⧇ āĻāĻ•āϟāĻŋ āĻāĻŦāĻ‚ āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ tabletāĨ¤

To be continued: āϕ⧋āύ⧋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻļ⧇āώ āϤāĻžāϰāĻŋāĻ– āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤ āĻāϰ āĻ…āĻ°ā§āĻĨ āĻ…āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟāĻ•āĻžāϞ āĻ“āώ⧁āϧ āĻ–āĻžāĻ“ā§ŸāĻž āύāĻŋāϰāĻžāĻĒāĻĻ āĻŦāĻž āĻ…āύ⧁āĻŽā§‹āĻĻāĻŋāĻ¤â€”āĻāĻŽāύ āύ⧟āĨ¤

āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ Clinical Safety Finding

Ornil 500 mg (Ornidazole) 1+0+1, "to be continued" — āĻāχ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāϟāĻŋ āĻŦāĻŋāĻļ⧇āώāĻ­āĻžāĻŦ⧇ āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

āĻ•āĻžāϰāĻŖ Ornidazole-āĻāϰ āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ neurological adverse effects-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžā§œāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ MedEx-āĻāϰ monograph-āĻ peripheral neuropathy āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ CNS disorders-āϕ⧇ contraindication āĻšāĻŋāϏ⧇āĻŦ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

āĻāχ āϰ⧋āĻ—ā§€āϰ āφāϗ⧇ āĻĨ⧇āϕ⧇āχ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ⧇āϰ āĻ…āĻ­āĻŋāϝ⧋āĻ— āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āϝāĻĻāĻŋāĻ“ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻŽāĻžāύ⧇āχ peripheral neuropathy āύ⧟, āϤāĻŦ⧁āĻ“ āĻĻā§€āĻ°ā§āϘāĻŽā§‡ā§ŸāĻžāĻĻāĻŋ Ornidazole treatment āĻļ⧁āϰ⧁ āĻŦāĻž āϚāĻžāϞāĻŋā§Ÿā§‡ āϝāĻžāĻ“ā§ŸāĻžāϰ āφāϗ⧇ neurological assessment āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

Medication identification confidence: 1.00 — based on your confirmed corrections.

Clinical safety confidence: 0.98


7. 🟩 PRESCRIBED DRUG ANALYSIS — MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€

7.1 Tablet Xionil 3 mg

1. Generic Name

Bromazepam — āĻŦā§āϰ⧋āĻŽāĻžāϜāĻŋāĻĒāĻžāĻŽāĨ¤

2. Brand Name

Xionil 3 mg Tablet

Manufacturer: SANDOZ (A Novartis Division)

3. MedEx Alternative Brands

MedEx-āĻ āĻĒāĻžāĻ“ā§ŸāĻž āĻāĻ•āχ generic-āĻāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ:

Tenil 3 mg, Siesta 3 mg, Restol 3 mg, Stressnil 3 mgāĨ¤

4. MedEx Therapeutic Class

Benzodiazepine sedatives

āĻŦāĻžāĻ‚āϞāĻž: āĻŦ⧇āύāĻœā§‹āĻĄāĻžā§ŸāĻžāϜāĻŋāĻĒāĻŋāύ āϜāĻžāĻ¤ā§€ā§Ÿ āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻŽāĻžāύ⧋āϰ āĻ“āώ⧁āϧāĨ¤

5. Pharmacological Class

Benzodiazepine / GABA-A receptor positive allosteric modulatorāĨ¤

6. Use / Purpose of the Drug

Bromazepam āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ:

  • Anxiety states — āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āωāĻĻā§āĻŦ⧇āĻ—āĨ¤
  • Acute tension — āϤ⧀āĻŦā§āϰ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒāĨ¤
  • Agitation — āĻ…āĻ¸ā§āĻĨāĻŋāϰāϤāĻžāĨ¤
  • Selected anxiety-associated insomnia — āωāĻĻā§āĻŦ⧇āĻ—āϜāύāĻŋāϤ āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤
  • Certain anxiety-related somatic symptoms — āωāĻĻā§āĻŦ⧇āĻ—-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

7. Why Doctor Prescribed This Drug in This Patient

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ:

āϰ⧋āĻ—ā§€āϰ genital discomfort-āĻāϰ āϏāĻ™ā§āϗ⧇ anxiety āĻŦāĻž sleep disturbance āĻĨāĻžāĻ•āϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āωāĻĒāϏāĻ°ā§āĻ— āĻ•āĻŽāĻžāύ⧋āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ Bromazepam āĻĻāĻŋā§Ÿā§‡ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āϤāĻŦ⧇ anxiety āĻŦāĻž insomnia āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ documented āύ⧟āĨ¤

Prescribing rationale confidence: 0.45

āĻāχ āĻ“āώ⧁āϧ vaginal infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ•āϰ⧇ āύāĻžāĨ¤

8. Side Effects of Drug

Common: Drowsiness, dizziness, fatigue, muscle weakness, reduced alertnessāĨ¤

Important: Dependence, memory impairment, ataxia āĻāĻŦāĻ‚ withdrawal symptomsāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϘ⧁āĻŽāϘ⧁āĻŽ āĻ­āĻžāĻŦ, āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž, āĻ­āĻžāϰāϏāĻžāĻŽā§āϝāĻšā§€āύāϤāĻž āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻ­āϰāĻļā§€āϞāϤāĻžāϰ āĻā§āρāĻ•āĻŋāĨ¤

9. MedEx Link

Xionil 3 mg — MedEx Bangladesh

10. Unit Price, Strip Price & Other Composition

Parameter Information
Unit price ā§ŗ5.87
Strip price (10 tablets) ā§ŗ58.70
15-tablet nominal cost ā§ŗ88.05
Original pack (50 tablets) ā§ŗ293.50
Other composition/strength āĻāχ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄā§‡āϰ āĻ…āĻ¨ā§āϝ strength āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āϤāĻžāϞāĻŋāĻ•āĻžāϭ⧁āĻ•ā§āϤ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋ

11. Mechanism of Action

Bromazepam GABA-A receptor-āĻāϰ inhibitory effect āĻŦ⧃āĻĻā§āϧāĻŋ āĻ•āϰ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŽāĻ¸ā§āϤāĻŋāĻˇā§āϕ⧇āϰ inhibitory neurotransmission āĻŦāĻžā§œāĻŋā§Ÿā§‡ āĻ¸ā§āύāĻžā§Ÿā§āϰ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āωāĻ¤ā§āϤ⧇āϜāύāĻž āĻ“ āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻŽāĻžā§ŸāĨ¤

12. Drug Indications

Anxiety, agitation, tension-associated symptoms āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ psychosomatic complaintsāĨ¤

13. Drug Interactions + Contraindications

Interactions: Alcohol, opioids, hypnotics, sedating antihistamines āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ CNS depressantsāĨ¤

Contraindications: Severe respiratory insufficiency, sleep apnoea, severe hepatic insufficiency āĻāĻŦāĻ‚ hypersensitivityāĨ¤

14. Precautions & Warnings

Dependence āĻāĻŦāĻ‚ withdrawal-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻ—āĻžā§œāĻŋ āϚāĻžāϞāĻžāύ⧋, machinery operate āĻ•āϰāĻž āĻāĻŦāĻ‚ alcohol āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

15. Dosage & Administration

Doctor's Prescription:

Xionil 3 mg — 0+0+1 for 15 days.

āĻŦāĻžāĻ‚āϞāĻž: āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ āĻ•āϰ⧇ ā§§ā§Ģ āĻĻāĻŋāύāĨ¤

āĻāϟāĻŋ historical prescription-āĻāϰ transcription; āĻŦāĻ°ā§āϤāĻŽāĻžāύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻļ⧁āϰ⧁āϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āύ⧟āĨ¤

16. Pregnancy & Lactation

Pregnancy-āϤ⧇ routine use āωāĻĒāϝ⧁āĻ•ā§āϤ āύ⧟āĨ¤ Breastfeeding-āĻāϰ āϏāĻŽā§Ÿ āĻā§œāĻŋā§Ÿā§‡ āϚāϞāĻž āĻŦāĻž specialist benefit–risk evaluation āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Drug information confidence: 0.99


7.2 Tablet Zithrox 500 mg

1. Generic Name

Azithromycin Dihydrate — āĻāϜāĻŋāĻĨā§āϰ⧋āĻŽāĻžāχāϏāĻŋāύ āĻĄāĻžāχāĻšāĻžāχāĻĄā§āϰ⧇āϟāĨ¤

2. Brand Name

Zithrox 500 mg Tablet

Manufacturer: Eskayef Pharmaceuticals Ltd.

3. MedEx Alternative Brands

Zitrex 500 mg, Zithrolex 500 mg āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ Azithromycin brandsāĨ¤

4. MedEx Therapeutic Class

Macrolides

āĻŦāĻžāĻ‚āϞāĻž: āĻŽā§āϝāĻžāĻ•ā§āϰ⧋āϞāĻžāχāĻĄ āĻļā§āϰ⧇āĻŖāĻŋāϰ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžā§Ÿā§‹āϟāĻŋāĻ•āĨ¤

5. Pharmacological Class

Azalide antibiotic — Macrolide subclassāĨ¤

6. Use / Purpose of the Drug

Azithromycin āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ susceptible bacterial infections-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ, āϝ⧇āĻŽāύ:

Respiratory tract infections: āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ āĻļā§āĻŦāĻžāϏāϤāĻ¨ā§āĻ¤ā§āϰ⧇āϰ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϜāύāĻŋāϤ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

Skin and soft-tissue infections: āĻ¤ā§āĻŦāĻ• āĻ“ āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

Chlamydial cervicitis/urethritis: āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϝ⧌āύāĻŦāĻžāĻšāĻŋāϤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϜāύāĻŋāϤ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

āϰ⧋āĻ—ā§€āϰ vaginal āĻ“ urethral burning āĻĨāĻžāĻ•āĻžā§Ÿ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• bacterial cervicitis āĻ…āĻĨāĻŦāĻž urethritis āϏāĻ¨ā§āĻĻ⧇āĻš āĻ•āϰ⧇ Azithromycin āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ āϕ⧋āύ⧋ cervical examination āĻŦāĻž Chlamydia testing āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

Prescribing rationale confidence: 0.50

Clinical Warning

Azithromycin 500 mg once daily for seven days is not the CDC standard regimen for uncomplicated chlamydial cervicitis.

CDC-āϰ cervicitis guideline-āĻ doxycycline 100 mg twice daily for seven days recommended regimen āĻāĻŦāĻ‚ azithromycin 1 g single dose alternative regimen āĻšāĻŋāϏ⧇āĻŦ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻ…āϤāĻāĻŦ, āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϏāĻžāϤ āĻĻāĻŋāύ⧇āϰ course-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

8. Side Effects of Drug

Common: Nausea, vomiting, abdominal pain, diarrhoeaāĨ¤

Serious: QT prolongation, arrhythmia, severe allergy āĻāĻŦāĻ‚ liver injuryāĨ¤

9. MedEx Link

Zithrox 500 mg — MedEx Bangladesh

10. Unit Price, Strip Price & Other Composition

Parameter Information
Unit price ā§ŗ40.00
Strip price (6 tablets) ā§ŗ240.00
Seven-tablet nominal cost ā§ŗ280.00
Other strength 250 mg tablet
Other formulation 200 mg/5 mL suspension

11. Mechanism of Action

Azithromycin bacterial 50S ribosomal subunit-āĻāϰ āϏāĻ™ā§āϗ⧇ āϝ⧁āĻ•ā§āϤ āĻšā§Ÿā§‡ protein synthesis āĻŦāĻžāϧāĻž āĻĻā§‡ā§ŸāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ protein āϤ⧈āϰāĻŋ āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇ āĻœā§€āĻŦāĻžāϪ⧁āϰ āĻŦ⧃āĻĻā§āϧāĻŋ āĻŦāĻžāϧāĻžāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇āĨ¤

12. Drug Indications

Susceptible respiratory infections, skin infections āĻāĻŦāĻ‚ selected STI-associated infectionsāĨ¤

13. Drug Interactions + Contraindications

Interactions: QT-prolonging drugs, selected anticoagulants āĻāĻŦāĻ‚ antacids-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āϏāĻŽā§Ÿ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Contraindications: Macrolide hypersensitivity āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇ Azithromycin-associated severe hepatic reactionāĨ¤

14. Precautions & Warnings

Antibiotic resistance, cardiac arrhythmia risk āĻāĻŦāĻ‚ hepatic impairment āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

15. Dosage & Administration

Doctor's Prescription:

Zithrox 500 mg — 0+0+1 for 7 days.

āĻŦāĻžāĻ‚āϞāĻž: āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ āĻ•āϰ⧇ āϏāĻžāϤ āĻĻāĻŋāύāĨ¤

Clinical note: āĻāχ regimen āϕ⧋āύ⧋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ genital infection-āĻāϰ guideline-standard āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ…āύ⧁āĻŽāĻžāύ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤ Original indication āϝāĻžāϚāĻžāχ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

16. Pregnancy & Lactation

āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ pregnancy-āϤ⧇ Azithromycin āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžā§Ÿ, āĻ•āĻŋāĻ¨ā§āϤ⧁ indication āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Breastfeeding-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ infant gastrointestinal symptoms āĻĒāĻ°ā§āϝāĻŦ⧇āĻ•ā§āώāĻŖ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Drug information confidence: 0.99


7.3 Tablet Riboflavine 5 mg

1. Generic Name

Riboflavin — Vitamin B2āĨ¤

2. Brand Name

Riboflavine 5 mg Tablet

MedEx-āĻ Riboflavine āύāĻžāĻŽā§‡ āĻāĻ•āĻžāϧāĻŋāĻ• āĻĒā§āϰāĻ¸ā§āϤ⧁āϤāĻ•āĻžāϰāϕ⧇āϰ product āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āωāĻĻāĻžāĻšāϰāĻŖ: Pharmadesh Laboratories Ltd., Indo Bangla Pharmaceutical āĻāĻŦāĻ‚ Bristol Pharmaceuticals Ltd.

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ manufacturer āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχāĨ¤

3. MedEx Alternative Brands

Riboflavin, Ribomin, Ribosina, Riboson, RibovitāĨ¤

4. MedEx Therapeutic Class

Vitamin-B preparations

āĻŦāĻžāĻ‚āϞāĻž: āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ āϜāĻžāĻ¤ā§€ā§Ÿ āĻĒā§āϰāĻ¸ā§āϤ⧁āϤāĻŋāĨ¤

5. Pharmacological Class

Water-soluble vitamin / Essential micronutrientāĨ¤

6. Use / Purpose of the Drug

Vitamin B2 deficiency āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ“ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

āĻŦāĻŋāĻļ⧇āώāϤ:

  • Cheilosis — āĻ ā§‹āρāĻŸā§‡āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āĻĢāĻžāϟāĻžāĨ¤
  • Angular stomatitis — āĻŽā§āϖ⧇āϰ āϕ⧋āϪ⧇ āϘāĻžāĨ¤
  • Glossitis — āϜāĻŋāĻšā§āĻŦāĻžāϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  • Keratitis — āĻ•āĻ°ā§āύāĻŋ⧟āĻžāϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  • Seborrhoeic dermatitis — āĻ¤ā§āĻŦāϕ⧇āϰ āĻāĻ•āϟāĻŋ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

āϰ⧋āĻ—ā§€āϰ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• nutritional supplementation-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ Riboflavine āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āϤāĻŦ⧇ Riboflavin deficiency āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āĻšā§ŸāύāĻŋ āĻāĻŦāĻ‚ Vitamin B2 āĻāĻ•āĻž unexplained hand numbness-āĻāϰ standard treatment āύ⧟āĨ¤

āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻĨāĻžāĻ•āϞ⧇ vitamin B12 deficiency, diabetes, peripheral nerve entrapment āχāĻ¤ā§āϝāĻžāĻĻāĻŋ āĻĒ⧃āĻĨāĻ•āĻ­āĻžāĻŦ⧇ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Prescribing rationale confidence: 0.55

8. Side Effects of Drug

āϏāĻžāϧāĻžāϰāĻŖ āĻŽāĻžāĻ¤ā§āϰāĻžā§Ÿ āĻŦ⧇āĻļ āύāĻŋāϰāĻžāĻĒāĻĻāĨ¤

Possible effects: Bright yellow-orange urine āĻāĻŦāĻ‚ āωāĻšā§āϚ āĻŽāĻžāĻ¤ā§āϰāĻžā§Ÿ gastrointestinal discomfortāĨ¤

9. MedEx Link

Riboflavine 5 mg — MedEx Bangladesh

10. Unit Price, Strip Price & Other Composition

Parameter MedEx-listed information
Unit price ā§ŗ0.20â€“ā§ŗ0.28, manufacturer āĻ…āύ⧁āϝāĻžā§Ÿā§€
Pharmadesh 500-tablet pack ā§ŗ140.00
Pharmadesh 1000-tablet pack ā§ŗ210.00
Strip price āĻāχ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ bulk-pack listing-āĻ āύ⧇āχ
Other brand/formulation āĻāĻ•āχ generic-āĻāϰ 5 mg tablets āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻĒā§āϰāĻ¸ā§āϤ⧁āϤāĻ•āĻžāϰāϕ⧇āϰ

āĻāĻ• āĻŽāĻžāϏ⧇ ā§Ŧā§ĻāϟāĻŋ tablet-āĻāϰ nominal cost: āĻĒā§āϰāĻ¸ā§āϤ⧁āϤāĻ•āĻžāϰāĻ• āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĒā§āϰāĻžā§Ÿ ā§ŗ12â€“ā§ŗ16.80āĨ¤

11. Mechanism of Action

Vitamin B2 āĻĨ⧇āϕ⧇ FMN āĻāĻŦāĻ‚ FAD āϤ⧈āϰāĻŋ āĻšā§ŸāĨ¤

āĻāϗ⧁āϞ⧋ cellular energy production, oxidation–reduction reactions āĻāĻŦāĻ‚ normal tissue metabolism-āĻ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āώ⧇ āĻļāĻ•ā§āϤāĻŋ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻ“ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻŦāĻŋāĻĒāĻžāĻ•ā§€ā§Ÿ āĻ•āĻžāĻœā§‡ āϏāĻšāĻžā§ŸāϤāĻž āĻ•āϰ⧇āĨ¤

12. Drug Indications

Riboflavin deficiency āĻāĻŦāĻ‚ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ clinical manifestationsāĨ¤

13. Drug Interactions + Contraindications

Interactions: Phenobarbital, tricyclic antidepressants, anticholinergic medicines āĻ“ probenecid-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ interaction āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Contraindication: Known hypersensitivityāĨ¤

14. Precautions & Warnings

āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ­āĻžāϞ⧋āĻ­āĻžāĻŦ⧇ āϏāĻšā§āϝ āĻ•āϰāĻž āĻšā§ŸāĨ¤

āϤāĻŦ⧇ unexplained numbness-āĻāϰ āĻĒā§āϰāĻ•ā§ƒāϤ āĻ•āĻžāϰāĻŖ āĻ…āύ⧁āϏāĻ¨ā§āϧāĻžāύ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤

15. Dosage & Administration

Doctor's Prescription:

Riboflavine 5 mg — 1+0+1 for 1 month.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻ•āĻžāϞ⧇ āĻāĻ•āϟāĻŋ āĻ“ āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ āĻ•āϰ⧇ āĻāĻ• āĻŽāĻžāϏāĨ¤

Daily total: 10 mg/dayāĨ¤

16. Pregnancy & Lactation

āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ nutritional dose-āĻ āϏāĻžāϧāĻžāϰāĻŖāϤ āύāĻŋāϰāĻžāĻĒāĻĻāĨ¤ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ supplementation-āĻāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

Drug information confidence: 0.99


7.4 Tablet Ornil 500 mg

āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϏāĻ‚āĻļā§‹āϧāĻŋāϤ āĻ“āώ⧁āϧ

1. Generic Name

Ornidazole — āĻ…āĻ°ā§āύāĻŋāĻĄāĻžāϜāϞāĨ¤

2. Brand Name

Ornil 500 mg Tablet

Manufacturer: Opsonin Pharma Ltd.

3. MedEx Alternative Brands

āĻāĻ•āχ generic-āĻāϰ MedEx-listed brand:

Ornid 500 mg, Ornizol 500 mg, Robic 500 mg, Troniz 500 mg, Xynor 500 mgāĨ¤

4. MedEx Therapeutic Class

Amoebicides, Anti-diarrhoeal antiprotozoal

āĻāϟāĻŋ MedEx-āĻ āĻĒā§āϰāĻĻāĻ°ā§āĻļāĻŋāϤ exact Therapeutic ClassāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻ…ā§āϝāĻžāĻŽāĻŋāĻŦāĻž āĻ“ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒā§āϰ⧋āĻŸā§‹āĻœā§‹ā§ŸāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻ“āώ⧁āϧāĨ¤

5. Pharmacological Class

5-Nitroimidazole antiprotozoal and antibacterial agentāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āύāĻžāχāĻŸā§āϰ⧋āχāĻŽāĻŋāĻĄāĻžāϜāϞ āĻļā§āϰ⧇āĻŖāĻŋāϰ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻĒā§āϰ⧋āĻŸā§‹āĻœā§‹ā§ŸāĻžāϞ āĻ“ āĻ…ā§āϝāĻžāύāĻžāϰ⧋āĻŦāĻŋāĻ• āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ āĻ•āĻžāĻ°ā§āϝāĻ•āϰ āĻ“āώ⧁āϧāĨ¤

6. Use / Purpose of the Drug

Ornidazole āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ:

1. Trichomoniasis — āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

āϝ⧌āύāĻŦāĻžāĻšāĻŋāϤ āĻĒā§āϰ⧋āĻŸā§‹āĻœā§‹ā§ŸāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

2. Bacterial Vaginosis — āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏāĨ¤

āϝ⧋āύāĻŋāϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• microbiota āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšā§Ÿā§‡ anaerobic bacteria-āĻāϰ āφāϧāĻŋāĻ•ā§āϝ āĻšāĻ“ā§ŸāĻžāĨ¤

3. Amoebiasis — āĻ…ā§āϝāĻžāĻŽāĻŋāĻŦāĻŋ⧟āĻžāϏāĻŋāϏāĨ¤

āĻ…āĻ¨ā§āĻ¤ā§āϰ āĻŦāĻž āϞāĻŋāĻ­āĻžāϰ⧇ āĻ…ā§āϝāĻžāĻŽāĻŋāĻŦāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

4. Giardiasis — āϜāĻŋ⧟āĻžāĻ°ā§āĻĄāĻŋ⧟āĻžāϏāĻŋāϏāĨ¤

Giardia āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

5. Susceptible Anaerobic Infections — āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ…āĻ•ā§āϏāĻŋāĻœā§‡āύāĻŦāĻŋāĻšā§€āύ āĻĒāϰāĻŋāĻŦ⧇āĻļ⧇ āĻŦ⧃āĻĻā§āϧāĻŋ āĻĒāĻžāĻ“ā§ŸāĻž āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

āϰ⧋āĻ—ā§€āϰ vaginal burning āĻ“ genital discomfort āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻāχ āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Bacterial Vaginosis āĻ…āĻĨāĻŦāĻž Trichomoniasis āϏāĻ¨ā§āĻĻ⧇āĻš āĻ•āϰ⧇ Ornidazole āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ Ornidazole-āĻāϰ pharmacological spectrum āĻāχ āĻĻ⧁āϟāĻŋ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽā§āĻĒāĻ°ā§āĻ•āϝ⧁āĻ•ā§āϤāĨ¤

āϤāĻŦ⧇ vaginal discharge, odour, vaginal pH, wet mount āĻ…āĻĨāĻŦāĻž Trichomonas NAAT-āĻāϰ āϤāĻĨā§āϝ āύ⧇āχāĨ¤

āϏ⧁āϤāϰāĻžāĻ‚ āĻ“āώ⧁āϧāϟāĻŋ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āĻ•āĻžāϰāĻŖ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ inference āĻ•āϰāĻž āϏāĻŽā§āĻ­āĻŦ āĻšāϞ⧇āĻ“ āϰ⧋āĻ— āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

Prescribing rationale confidence: 0.65

Important Clinical Point

Ornidazole Candida infection-āĻāϰ standard treatment āύ⧟āĨ¤

āĻāϟāĻŋ uncomplicated bacterial cystitis-āĻāϰ first-line treatment-āĻ“ āύ⧟āĨ¤

8. Side Effects of Drug

Gastrointestinal: Nausea, vomiting, abdominal discomfortāĨ¤

Neurological: Dizziness, headache, somnolence, ataxia āĻāĻŦāĻ‚ neurological toxicity-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻžāĨ¤

Haematological: Rare leukopenia, āĻŦāĻŋāĻļ⧇āώāϤ prolonged treatment-āĻāĨ¤

9. MedEx Link

Ornil 500 mg — MedEx Bangladesh

10. Unit Price, Strip Price & Other Composition

Parameter Information
Unit price ā§ŗ7.00
Strip price (10 tablets) ā§ŗ70.00
Pack price (20 tablets) ā§ŗ140.00
Other listed strength for Ornil āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋ
Other Ornidazole brands Ornid, Ornizol, Robic, Troniz, Xynor

11. Mechanism of Action

Ornidazole susceptible anaerobic organisms-āĻāϰ āϭ⧇āϤāϰ⧇ reduced metabolites āϤ⧈āϰāĻŋ āĻ•āϰ⧇āĨ¤

āĻāχ metabolites microbial DNA-āĻāϰ structure āĻ“ function āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻœā§€āĻŦāĻžāϪ⧁āϰ DNA āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇ āĻœā§€āĻŦāĻžāϪ⧁āϰ āĻŦ⧃āĻĻā§āϧāĻŋ āĻ“ āĻŦ⧇āρāĻšā§‡ āĻĨāĻžāĻ•āĻžāϰ āĻ•ā§āώāĻŽāϤāĻž āύāĻˇā§āϟ āĻ•āϰ⧇āĨ¤

12. Drug Indications

Trichomoniasis, bacterial vaginosis, amoebiasis, giardiasis āĻāĻŦāĻ‚ susceptible anaerobic infectionsāĨ¤

13. Drug Interactions + Contraindications

Interactions: Oral anticoagulants, 5-fluorouracil āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ interacting medicinesāĨ¤

Contraindications: Nitroimidazole hypersensitivity āĻāĻŦāĻ‚ MedEx monograph āĻ…āύ⧁āϝāĻžā§Ÿā§€ epilepsy āĻŦāĻž peripheral neuropathy-āϏāĻš āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ neurological disordersāĨ¤

14. Precautions & Warnings

āĻāϟāĻŋ āĻāχ āϕ⧇āϏ⧇āϰ āĻāĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ safety considerationāĨ¤

āĻ•āĻžāϰāĻŖ āϰ⧋āĻ—ā§€āϰ āĻšāĻžāϤ⧇ numbness āφāϗ⧇ āĻĨ⧇āϕ⧇āχ documentedāĨ¤

āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ Ornidazole āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāϞ⧇ neurological adverse effects āĻāĻŦāĻ‚ āĻŦāĻŋāϰāϞ haematological complications āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻ…āϤāĻāĻŦ, āϰ⧋āĻ—ā§€āϰ neurological symptoms āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āύāĻž āĻ•āϰ⧇ indefinite treatment āϏāĻŽāĻ°ā§āĻĨāύāϝ⧋āĻ—ā§āϝ āύ⧟āĨ¤

15. Dosage & Administration

Doctor's Prescription:

Ornil 500 mg — 1+0+1, To be continued.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻ•āĻžāϞ⧇ āĻāĻ•āϟāĻŋ āĻāĻŦāĻ‚ āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋ; āĻ•āϤāĻĻāĻŋāύ āϚāϞāĻŦ⧇ āϤāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āύ⧟āĨ¤

Daily total: 1000 mg/dayāĨ¤

MedEx Dose Comparison

MedEx-listed indication-specific regimens-āĻāϰ āωāĻĻāĻžāĻšāϰāĻŖ:

Trichomoniasis: 500 mg twice daily for five days āĻ…āĻĨāĻŦāĻž listed alternative regimenāĨ¤

Bacterial Vaginosis: 500 mg once daily for five āĻĨ⧇āϕ⧇ āϏāĻžāϤ āĻĻāĻŋāύ āĻ…āĻĨāĻŦāĻž listed alternative regimenāĨ¤

āĻāϗ⧁āϞ⧋ āĻŽā§‚āϞ prescription-āĻāϰ āύāϤ⧁āύ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āύ⧟āĨ¤ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āφāĻ¨ā§āϤāĻ°ā§āϜāĻžāϤāĻŋāĻ• guideline-āĻ āĻ…āĻ¨ā§āϝ nitroimidazole, āĻŦāĻŋāĻļ⧇āώāϤ metronidazole-based regimens āĻ…āĻ—ā§āϰāĻžāϧāĻŋāĻ•āĻžāϰ āĻĒāĻžā§ŸāĨ¤

Critical Clinical Interpretation

"To be continued" is not an acceptable standalone duration for long-term ornidazole therapy without a clearly documented indication and review plan.

āĻŦāĻžāĻ‚āϞāĻž: āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϰ⧋āĻ—, āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻ“ stop date āĻ›āĻžā§œāĻž āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ Ornidazole āϚāĻžāϞāĻžāύ⧋ āωāϚāĻŋāϤ āύ⧟āĨ¤

16. Pregnancy & Lactation

Pregnancy āĻ“ lactation-āĻ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ clinical safety data āϏ⧀āĻŽāĻŋāϤāĨ¤

āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ specialist benefit–risk assessment āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Drug information confidence: 0.99

Case-specific treatment-duration safety concern: 0.98


8. 🩷 Bangladesh Clinical Practice — Vulvovaginitis Medicines Used by Doctors

āĻāĻ–āĻžāύ⧇ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āωāĻĒāϞāĻŦā§āϧ āĻ“ āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āφāϞāĻžāĻĻāĻžāĻ­āĻžāĻŦ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āĻšā§Ÿā§‡āϛ⧇āĨ¤

āĻāϗ⧁āϞ⧋ āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ“āώ⧁āϧ āύ⧟āĨ¤ āϰ⧋āĻ— āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻ“ā§ŸāĻžāϰ āĻĒāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāĻ•āϟāĻŋ āωāĻĒāϝ⧁āĻ•ā§āϤ treatment pathway āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšā§ŸāĨ¤

Table 2 — Disease-Specific Medicine Options

No. Generic Brand example MedEx Therapeutic Class Pharmacological Class Clinical use
1 Clotrimazole Afun VT 200 mg Drugs used in Vaginal and Vulval condition, Topical Antifungal preparations Imidazole antifungal Confirmed vaginal candidiasis
2 Fluconazole Flugal 150 mg Systemic antifungal medicine Triazole antifungal Selected nonpregnant candidiasis
3 Metronidazole Filmet 400 mg Amoebicides, Anti-diarrhoeal antiprotozoal Nitroimidazole Bacterial vaginosis / Trichomoniasis
4 Ornidazole Ornil 500 mg Amoebicides, Anti-diarrhoeal antiprotozoal Nitroimidazole Selected anaerobic/protozoal infection
5 Nitrofurantoin Nitrofur SR 100 mg Systemic Urinary Anti-infective Nitrofuran antibiotic Susceptible lower UTI
6 Fosfomycin Trometamol Monuril 3 g Intracellular antibiotic Phosphonic acid antibiotic Selected uncomplicated cystitis
7 Azithromycin Zithrox 500 mg Macrolides Azalide antibiotic Selected bacterial cervicitis
8 Riboflavin Riboflavine 5 mg Vitamin-B preparations Water-soluble vitamin Vitamin B2 deficiency

Clinical note: āĻāĻ–āĻžāύ⧇ MedEx-āĻāϰ Therapeutic Class āĻāĻŦāĻ‚ pharmacological class āφāϞāĻžāĻĻāĻž āϰāĻžāĻ–āĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤ Drug classes-āĻāϰ āĻ•āĻŋāϛ⧁ āύāĻžāĻŽ MedEx-āĻāϰ āύāĻŋāϜāĻ¸ā§āĻŦ classification āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

Table 3 — Bangladesh Drug Price & MedEx Links

No. Drug Unit price Strip/pack price MedEx
1 Afun VT 200 mg ā§ŗ20.06 3 tablets: ā§ŗ60.18 View
2 Flugal 150 mg ā§ŗ22.14 10 capsules: ā§ŗ221.40 View
3 Filmet 400 mg ā§ŗ1.70 10 tablets: ā§ŗ17.00 View
4 Ornil 500 mg ā§ŗ7.00 10 tablets: ā§ŗ70.00 View
5 Nitrofur SR 100 mg ā§ŗ26.00 10 capsules: ā§ŗ260.00 View
6 Monuril 3 g ā§ŗ350.00 One sachet: ā§ŗ350.00 View
7 Zithrox 500 mg ā§ŗ40.00 6 tablets: ā§ŗ240.00 View
8 Riboflavine 5 mg ā§ŗ0.20–0.28 Bulk packs; manufacturer-dependent View

Prices: MedEx-āĻ āĻĒā§āϰāĻĻāĻ°ā§āĻļāĻŋāϤ āĻŽā§‚āĻ˛ā§āϝ; āĻŦāĻžāϜāĻžāϰ⧇ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Clinical Selection — āϕ⧋āύ āϰ⧋āϗ⧇ āϕ⧋āύ āĻ“āώ⧁āϧ?

Confirmed Candida Vaginitis: Clotrimazole vaginal preparations āĻ…āĻĨāĻŦāĻž āωāĻĒāϝ⧁āĻ•ā§āϤ nonpregnant āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ fluconazoleāĨ¤

Confirmed Bacterial Vaginosis: Metronidazole-based guideline regimen āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒāϗ⧁āϞ⧋āϰ āĻāĻ•āϟāĻŋāĨ¤

Confirmed Trichomoniasis: CDC āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻžāϰ⧀āĻĻ⧇āϰ āϜāĻ¨ā§āϝ metronidazole 500 mg twice daily for seven days recommendedāĨ¤

Confirmed Acute Uncomplicated Cystitis: Nitrofurantoin āĻ…āĻĨāĻŦāĻž āĻ…āĻ¨ā§āϝ guideline-supported antibiotic, renal function āĻ“ bacterial susceptibility āĻ…āύ⧁āϝāĻžā§Ÿā§€āĨ¤

Selected Cervicitis: STI testing āĻ“ risk āĻ…āύ⧁āϝāĻžā§Ÿā§€ doxycycline āĻŦāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ alternative regimenāĨ¤

Clinical confidence: 0.97


9. 🟨 MY CLINICAL WORKING ASSESSMENT

9.1 đŸŸĒ Prescription-Ready Provisional Diagnosis

Vulvovaginal and Urethral Burning/Pain of Undetermined Etiology — Suspected Vulvovaginitis; Evaluate for Bacterial Vaginosis, Trichomoniasis, Cervicitis and Acute Cystitis. Associated Hand Paresthesia. H/O Cervical Erosion and D&C/ECC.

āĻŦāĻžāĻ‚āϞāĻž Diagnosis

āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž, āϝāĻžāϰ āĻ•āĻžāϰāĻŖ āĻāĻ–āύ⧋ āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏ, āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻŋ⧟āĻžāϏāĻŋāϏ, āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ“ āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻ°ā§Ÿā§‡āϛ⧇ āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇ Cervical Erosion āĻ“ D&C/ECC-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āφāϛ⧇āĨ¤

Clinical Confidence

Working assessment Confidence
Vaginal/urethral burning and pain documented 0.98
Hand numbness documented 0.96
Previous cervical procedure documented 0.85
Vulvovaginitis possible 0.75
Bacterial vaginosis possible 0.60
Trichomoniasis possible 0.50
Cervicitis possible 0.50
Acute cystitis possible 0.55
Infection confirmed by laboratory testing Not established

Interpretation: āĻāχ scores clinical certainty-āĻāϰ āφāύ⧁āĻŽāĻžāύāĻŋāĻ• āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ; calibrated diagnostic probability āύ⧟āĨ¤


9.2 đŸŸĒ Specific Specialist Department / Doctor Referral

Primary Referral

Consultant Obstetrician & Gynaecologist

āĻŦāĻžāĻ‚āϞāĻž: āĻ¸ā§āĻ¤ā§āϰ⧀āϰ⧋āĻ— āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĨ¤

Referral indication: Vaginal and urethral burning, suspected vulvovaginitis, assessment for genital/urinary infection, prior cervical procedure history āĻāĻŦāĻ‚ treatment reviewāĨ¤

Secondary Referral

Medicine Specialist / Neurologist

āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āϚāϞāϤ⧇ āĻĨāĻžāĻ•āϞ⧇ āĻŦāĻž neurological findings āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇āĨ¤

Urologist

Recurrent UTI āĻ…āĻĨāĻŦāĻž persistent unexplained urinary symptoms āĻĨāĻžāĻ•āϞ⧇āĨ¤


9.3 🟧 Clinical Diagnosis — Severity / Category / Complications

Disease category: Genitourinary symptom complex with suspected vulvovaginal inflammationāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϰ āωāĻĒāϏāĻ°ā§āĻ—āϏāĻš āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

Severity: UndeterminedāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϰ⧋āϗ⧇āϰ āϤ⧀āĻŦā§āϰāϤāĻž āύāĻŋāĻ°ā§āϧāĻžāϰāϪ⧇āϰ āϜāĻ¨ā§āϝ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āύ⧇āχāĨ¤

Complications: None documentedāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āύ⧋ complication āύāĻĨāĻŋāϤ⧇ āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ; āϤāĻŦ⧇ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ examination āĻ›āĻžā§œāĻž āĻ…āύ⧁āĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤


10. 🟧 Doctor's Dx vs 🟩 My Clinical Dx

🟧 DOCTOR'S DOCUMENTED DIAGNOSIS

No clearly written definitive current diagnosis.

āĻĄāĻžāĻ•ā§āϤāĻžāϰ Cervical Erosion āĻ“ āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ procedure-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āϛ⧇āύāĨ¤

āĻ“āώ⧁āϧ⧇āϰ āĻŽāĻ§ā§āϝ⧇ Azithromycin āĻ“ Ornidazole āĻĨāĻžāĻ•āĻžā§Ÿ bacterial/protozoal infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĻ⧇āĻ“ā§ŸāĻžāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻāϟāĻŋ prescribing intent-āĻāϰ inference, diagnosis-āĻāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧟āĨ¤

🟩 MY CLINICAL WORKING DIAGNOSIS

Suspected Vulvovaginitis with Vaginal/Urethral Burning; R/O Bacterial Vaginosis, Trichomoniasis, Cervicitis and Acute Cystitis; Associated Hand Paresthesia.

Diagnosis Comparison

Parameter Doctor My Assessment Comparison
Vaginal burning Documented Included đŸŸĸ Similar
Urethral discomfort Documented Included đŸŸĸ Similar
Hand numbness Documented Included đŸŸĸ Similar
Cervical erosion Past history Past history đŸŸĸ Similar
Current bacterial infection Not confirmed Possible 🟠 Cannot establish agreement
BV / Trichomoniasis No explicit diagnosis Rule out 🟠 Additional differential
UTI No explicit diagnosis Rule out 🟠 Additional differential
Definitive diagnosis Not documented Not established đŸŸĸ Similar evidence status

Final Comparison Result

Doctor's diagnosis āĻāĻŦāĻ‚ My diagnosis āĻāĻ•āχ āĻ•āĻŋ āύāĻž?

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻāĻ•āϟāĻŋ āĻ¸ā§āĻĒāĻˇā§āϟ āĻŦāĻ°ā§āϤāĻŽāĻžāύ diagnosis āύāĻž āĻĨāĻžāĻ•āĻžā§Ÿ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ agreement āĻ…āĻĨāĻŦāĻž disagreement āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

āϤāĻŦ⧇ āϰ⧋āĻ—ā§€āϰ documented symptoms-āĻāϰ āϏāĻ™ā§āϗ⧇ working diagnosis āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āĻŽā§‚āϞ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ: āφāĻŽāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇ āĻāĻ•āĻžāϧāĻŋāĻ• āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ āĻĒ⧃āĻĨāĻ• āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇ āĻāĻŦāĻ‚ diagnosis āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻžāϰ investigation plan āϝ⧁āĻ•ā§āϤ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

Comparison confidence: 0.97


11. Definition — Disease Overview

Vulvovaginitis

Definition: Inflammation or irritation of the vulva and vaginaāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāϰ āĻŦāĻžāχāϰ⧇āϰ āĻ…āĻ‚āĻļ āĻ“ āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āĻœā§āĻŦāĻžāϞāĻžāĨ¤

āĻāϟāĻŋ bacterial, fungal, protozoal āĻ…āĻĨāĻŦāĻž noninfectious āĻ•āĻžāϰāϪ⧇ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Bacterial Vaginosis

Definition: Vaginal dysbiosis characterized by reduced lactobacilli and increased anaerobic bacteriaāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āωāĻĒāĻ•āĻžāϰ⧀ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻž āĻ•āĻŽā§‡ āĻ—āĻŋā§Ÿā§‡ āĻ…āĻ¨ā§āϝ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ āφāϧāĻŋāĻ•ā§āϝ āĻšāĻ“ā§ŸāĻžāĨ¤

Trichomoniasis

Definition: Infection caused by Trichomonas vaginalisāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧌āύāĻŦāĻžāĻšāĻŋāϤ āĻĒā§āϰ⧋āĻŸā§‹āĻœā§‹ā§ŸāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

Cervicitis

Definition: Inflammation of the cervixāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤

Acute Cystitis

Definition: Infection or inflammation of the urinary bladderāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

Reference: CDC STI Guidelines, 2021āĨ¤


12. Etiology & Pathophysiology

A. Bacterial Vaginosis

Vaginal lactobacilli āĻ•āĻŽā§‡ āĻ—āĻŋā§Ÿā§‡ anaerobic bacteria āĻŦ⧃āĻĻā§āϧāĻŋ āĻĒ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻāϤ⧇ vaginal pH āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšā§Ÿ āĻāĻŦāĻ‚ abnormal discharge āĻŦāĻž odour āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

B. Trichomoniasis

Trichomonas vaginalis genital mucosa-āϤ⧇ inflammatory response āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰ⧇āĨ¤

āĻāϤ⧇ genital irritation, discharge āĻāĻŦāĻ‚ dysuria āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

C. Candida Vaginitis

Candida species-āĻāϰ āĻ…āϤāĻŋāĻŦ⧃āĻĻā§āϧāĻŋ vulvovaginal inflammation āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϏāĻžāϧāĻžāϰāĻŖāϤ itching, soreness āĻāĻŦāĻ‚ external dysuria āĻŦ⧇āĻļāĻŋ āĻĻ⧇āĻ–āĻž āϝāĻžā§ŸāĨ¤

D. Acute Cystitis

Uropathogenic bacteria urethra āĻĻāĻŋā§Ÿā§‡ bladder-āĻ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇ infection āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

E. Noninfectious Irritation

Perfumed soap, antiseptic wash, lubricants āĻŦāĻž contact allergens-āĻ“ vaginal burning āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Clinical point: āĻāĻ•āχ āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āĻāĻ•āĻžāϧāĻŋāĻ• āĻ•āĻžāϰāĻŖ āϏāĻŽā§āĻ­āĻŦāĨ¤ āϤāĻžāχ antibiotic selection āĻĻ⧇āϖ⧇ āϰ⧋āĻ— āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤


13. Clinical Features & Differential Diagnosis

Disease Typical clinical clues Current patient evidence
Bacterial Vaginosis Thin discharge, fishy odour, elevated vaginal pH Burning documented; āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϤāĻĨā§āϝ āύ⧇āχ
Trichomoniasis Irritation, dysuria, discharge Burning āφāϛ⧇; testing āĻšā§ŸāύāĻŋ
Candida Vaginitis Itching, redness, thick discharge āĻāϏāĻŦ āϤāĻĨā§āϝ āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
Cervicitis Cervical discharge, bleeding, cervical inflammation Examination āύ⧇āχ
Acute Cystitis Dysuria, frequency, urgency Urethral burning āφāϛ⧇; frequency/urgency āύ⧇āχ
Contact Vulvitis Burning after soap/chemical exposure Exposure history āύ⧇āχ
Pelvic Inflammatory Disease Pelvic pain, fever, pelvic tenderness Supporting findings āύ⧇āχ

Differential Diagnosis Conclusion

Most defensible diagnosis: Vulvovaginal and urethral burning of undetermined etiologyāĨ¤

Most important infectious conditions to evaluate: BV, Trichomoniasis, Cervicitis, Cystitis āĻāĻŦāĻ‚ CandidiasisāĨ¤

Confidence: 0.95


14. Investigations — āϕ⧀ āϕ⧀ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύ?

A. Doctor's Investigations

No clear investigations prescribed in the visible note.

B. My Recommended Investigations

Investigation Clinical purpose āĻŦāĻžāĻ‚āϞāĻž
Urine R/E Evaluate urinary inflammation āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇ āĻĒā§āϰāĻĻāĻžāĻšā§‡āϰ āϚāĻŋāĻšā§āύ
Urine Culture & Sensitivity When UTI is suspected and testing is indicated āĻœā§€āĻŦāĻžāϪ⧁ āĻ“ antibiotic sensitivity
Pregnancy Test If pregnancy is possible āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž āϝāĻžāϚāĻžāχ
Vaginal pH Support differential diagnosis of vaginitis āϝ⧋āύāĻŋāϰ pH āĻĒāϰ⧀āĻ•ā§āώāĻž
Vaginal Wet Mount Trichomonads, clue cells and yeast āĻœā§€āĻŦāĻžāϪ⧁ āĻ“ āϕ⧋āώāĻ—āϤ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻĻ⧇āĻ–āĻž
KOH Microscopy Candida evaluation āĻ›āĻ¤ā§āϰāĻžāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž
Vaginal NAAT Selected BV/Trichomonas/Candida assessment āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻļāύāĻžāĻ•ā§āϤ
Chlamydia/Gonorrhoea NAAT If STI/cervicitis suspected āϝ⧌āύāĻŦāĻžāĻšāĻŋāϤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻž āĻļāύāĻžāĻ•ā§āϤ
CBC If systemic illness or anaemia suspected āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻž
HbA1c / Blood Glucose If diabetes risk or persistent numbness āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ
Vitamin B12 If clinically indicated for paresthesia āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ B12 āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ

Clinical Priority

First: Clinical history āĻāĻŦāĻ‚ vulvovaginal/pelvic examinationāĨ¤

Second: Urinary symptoms āĻ…āύ⧁āϝāĻžā§Ÿā§€ urine testingāĨ¤

Third: Discharge āĻŦāĻž STI risk āĻ…āύ⧁āϝāĻžā§Ÿā§€ vaginal microscopy/NAATāĨ¤

Fourth: Hand numbness-āĻāϰ āĻĒ⧃āĻĨāĻ• neurological assessmentāĨ¤

CDC āĻŦāϞāϛ⧇, āĻļ⧁āϧ⧁ history āĻĻāĻŋā§Ÿā§‡ vaginitis-āĻāϰ āϏāĻ āĻŋāĻ• āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ…āύ⧇āĻ• āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻŽā§āĻ­āĻŦ āύ⧟; examination āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ laboratory testing āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

Investigation plan confidence: 0.97


15. Guideline-Based Management & Critical Prescription Review

A. Current Prescription Review

Xionil 3 mg

Reasonable only if: Anxiety, tension āĻ…āĻĨāĻŦāĻž āωāĻĒāϝ⧁āĻ•ā§āϤ āĻ…āĻ¨ā§āϝ indication āĻĨāĻžāϕ⧇āĨ¤

Concern: Sedation, dependence āĻāĻŦāĻ‚ withdrawal riskāĨ¤

Zithrox 500 mg

Reasonable only if: Susceptible bacterial infection-āĻāϰ āϝāĻĨāĻžāϝāĻĨ indication āĻĨāĻžāϕ⧇āĨ¤

Concern: 500 mg daily for seven days—āĻŦāĻ°ā§āϤāĻŽāĻžāύ suspected genital infection-āĻāϰ āϕ⧋āύ diagnosis āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇, āϤāĻž āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āύ⧟āĨ¤

Riboflavine 5 mg

Reasonable if: Vitamin B2 deficiency āĻŦāĻž supplementation-āĻāϰ āωāĻĒāϝ⧁āĻ•ā§āϤ āĻ•āĻžāϰāĻŖ āĻĨāĻžāϕ⧇āĨ¤

Concern: Hand numbness-āĻāϰ āĻŽā§‚āϞ āĻ•āĻžāϰāĻŖ āĻ…āϜāĻžāύāĻžāĨ¤

Ornil 500 mg

Reasonable only if: Suitable anaerobic/protozoal infection-āĻāϰ indication āĻĨāĻžāϕ⧇āĨ¤

Concern: Duration unspecified, āĻāĻŦāĻ‚ āϰ⧋āĻ—ā§€āϰ āφāϗ⧇ āĻĨ⧇āϕ⧇āχ numbness āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Three Main Weak Points in the Prescription

1. No definite infectious diagnosis.

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āύ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϜāĻ¨ā§āϝ antibiotic āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇, āϤāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤

2. Zithrox regimen requires indication-specific review.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻžāϤ āĻĻāĻŋāύ⧇āϰ Azithromycin regimen āϕ⧇āύ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇, āϤāĻž āϝāĻžāϚāĻžāχ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

3. Ornidazole duration is undefined despite neurological symptoms.

āĻŦāĻžāĻ‚āϞāĻž: āϰ⧋āĻ—ā§€āϰ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻĨāĻžāĻ•āĻž āĻ…āĻŦāĻ¸ā§āĻĨāĻžā§Ÿ Ornidazole āĻ•āϤāĻĻāĻŋāύ āϚāϞāĻŦ⧇ āϤāĻž āĻ¸ā§āĻĒāĻˇā§āϟ āύāĻž āĻšāĻ“ā§ŸāĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ safety concernāĨ¤


B. If Bacterial Vaginosis Is Confirmed

CDC-recommended regimen-āĻāϰ āĻāĻ•āϟāĻŋ:

Metronidazole 500 mg orally twice daily for seven days.

āĻāĻ›āĻžā§œāĻž vaginal metronidazole gel āĻ…āĻĨāĻŦāĻž clindamycin cream-āĻāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ regimen āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻāϟāĻŋ Ornil-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻāĻ•āϏāĻ™ā§āϗ⧇ āϝ⧋āĻ— āĻ•āϰāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āύ⧟āĨ¤ āϰ⧋āĻ—ā§€āϰ history, pregnancy status āĻ“ contraindications āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

C. If Trichomoniasis Is Confirmed

CDC āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻžāϰ⧀āĻĻ⧇āϰ āϜāĻ¨ā§āϝ:

Metronidazole 500 mg orally twice daily for seven days.

Sexual partner evaluation āĻ“ treatment āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Treatment āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻšāĻ“ā§ŸāĻž āĻāĻŦāĻ‚ symptoms resolve āύāĻž āĻšāĻ“ā§ŸāĻž āĻĒāĻ°ā§āϝāĻ¨ā§āϤ intercourse āĻā§œāĻŋā§Ÿā§‡ āϚāϞāĻžāϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§ŸāĨ¤

D. If Candida Infection Is Confirmed

Topical azole therapy āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤

Nonpregnant uncomplicated candidiasis-āĻāϰ āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ oral fluconazole āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšā§ŸāĨ¤

Pregnancy: CDC āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϏāĻžāϤ āĻĻāĻŋāύ⧇āϰ topical azole therapy āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤ; oral fluconazole routine treatment āĻšāĻŋāϏ⧇āĻŦ⧇ āϏ⧁āĻĒāĻžāϰāĻŋāĻļ āĻ•āϰāĻž āĻšā§Ÿ āύāĻžāĨ¤

E. If Acute Cystitis Is Confirmed

NICE NG109 āĻ…āύ⧁āϝāĻžā§Ÿā§€ nonpregnant women-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ nitrofurantoin āĻ…āĻĨāĻŦāĻž āωāĻĒāϝ⧁āĻ•ā§āϤ āĻ…āĻ¨ā§āϝ antibiotic āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤

Renal function, pregnancy, bacterial susceptibility āĻāĻŦāĻ‚ local resistance āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

F. If Cervicitis Is Diagnosed

Chlamydia āĻ“ Gonorrhoea testing āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

CDC guideline āĻ…āύ⧁āϝāĻžā§Ÿā§€ āωāĻĒāϝ⧁āĻ•ā§āϤ nonpregnant patients-āĻāϰ āϜāĻ¨ā§āϝ doxycycline-based treatment standard optionāĨ¤

Clinical management confidence: 0.97


16. Real Prescription Demo — Clinical Working Assessment

This is a documentation example, not a new treatment prescription.

LIPU MED — GYNECOLOGY CLINICAL NOTE

Patient: Female; age not verified

Original Visit: 21 April 2025

C/C:

Pain and burning sensation in vaginal and urethral region.

Numbness in hand.

M/H:

LMP approximately 10/04/2025.

Menstrual duration six days.

Regular cycle.

Average menstrual flow.

No documented dysmenorrhoea.

O/H:

P3, NVD × 3 — to verify.

Past H/O:

Cervical Erosion.

D&C/ECC — procedure details and histopathology report unavailable.

O/E:

Weight approximately 81 kg.

BP approximately 100/80 mmHg.

Pelvic examination findings not documented.

đŸŸĒ Provisional Diagnosis

Vulvovaginal and Urethral Burning/Pain — Etiology Undetermined; Suspected Vulvovaginitis; R/O Bacterial Vaginosis, Trichomoniasis, Cervicitis and Acute Cystitis. Associated Hand Paresthesia.

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻŦā§āϝāĻĨāĻž āĻ“ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž; āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏ, āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻŋ⧟āĻžāϏāĻŋāϏ, āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ‚ āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āφāϛ⧇ āĻ•āĻŋ āύāĻž āϝāĻžāϚāĻžāχ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤ āϏāĻ™ā§āϗ⧇ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦāĨ¤

Original Prescription — Corrected Transcription

Medicine Dose Duration
Tab. Xionil 3 mg 0+0+1 15 days
Tab. Zithrox 500 mg 0+0+1 7 days
Tab. Riboflavine 5 mg 1+0+1 1 month
Tab. Ornil 500 mg 1+0+1 To be continued — duration clarification required

Important: āĻāχ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ ⧍ā§Ļ⧍ā§Ģ āϏāĻžāϞ⧇āϰ prescription-āĻāϰ historical transcriptionāĨ¤ ⧍ā§Ļ⧍ā§Ŧ āϏāĻžāϞ⧇ āύāϤ⧁āύ āĻ•āϰ⧇ āĻļ⧁āϰ⧁ āĻŦāĻž āϚāĻžāϞāĻŋā§Ÿā§‡ āϝāĻžāĻ“ā§ŸāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Investigation Plan

Clinical assessment āĻ…āύ⧁āϝāĻžā§Ÿā§€ urine testing, vaginal examination, wet mount/NAAT āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ STI testingāĨ¤

Review Plan

Clarify the indication for both antimicrobial agents and the stop date of Ornidazole.

Assess hand numbness and relevant neurological risk before considering prolonged nitroimidazole exposure.

Referral

Consultant Obstetrician & Gynaecologist

Additional Medicine/Neurology consultation if paresthesia persists or progressesāĨ¤


17. Final Clinical Assessment

Overview / Summary

āĻāχ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāϧāĻžāύ documented āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϞ⧋ āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻžāĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻĒā§‚āĻ°ā§āĻŦ⧇ Cervical Erosion āĻāĻŦāĻ‚ D&C/ECC-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇āĨ¤

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϚāĻžāϰāϟāĻŋ āĻ“āώ⧁āϧ āĻĻāĻŋā§Ÿā§‡āϛ⧇āύ:

Xionil — Bromazepam: āωāĻĻā§āĻŦ⧇āĻ— āĻŦāĻž āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āωāĻĒāϏāĻ°ā§āĻ— āĻ•āĻŽāĻžāύ⧋āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝāĨ¤

Zithrox — Azithromycin: āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ bacterial infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝāĨ¤

Riboflavine — Vitamin B2: nutritional supplementation-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝāĨ¤

Ornil — Ornidazole: anaerobic/protozoal genital infection-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

āϤāĻŦ⧇ drug selection āĻĨ⧇āϕ⧇ definitive diagnosis āϤ⧈āϰāĻŋ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

Final Confidence Table

Conclusion Confidence
Corrected drug identification 1.00
Corrected dosing transcription 1.00
Vaginal/urethral symptoms documented 0.98
Hand numbness documented 0.96
Previous cervical procedure history 0.85
Suspected vulvovaginal inflammation 0.75
BV is a possible cause 0.60
Trichomoniasis is a possible cause 0.50
Cervicitis is a possible cause 0.50
Cystitis is a possible cause 0.55
Need to clarify prolonged Ornil use 0.98
Definitive laboratory-confirmed diagnosis Not established

Final Diagnostic Statement

Vulvovaginal and Urethral Burning/Pain of Undetermined Etiology, with Suspected Vulvovaginitis; Evaluate for Bacterial Vaginosis, Trichomoniasis, Cervicitis and Acute Cystitis. Associated Hand Paresthesia. H/O Cervical Erosion and D&C/ECC.

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧋āύāĻŋāĻĒāĻĨ āĻ“ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž, āϝāĻžāϰ āϏāĻ āĻŋāĻ• āĻ•āĻžāϰāĻŖ āĻāĻ–āύāĻ“ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āĻšā§ŸāύāĻŋāĨ¤ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏ, āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻŋ⧟āĻžāϏāĻŋāϏ, āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ‚ āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻ°ā§Ÿā§‡āϛ⧇ āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇ Cervical Erosion āĻ“ D&C/ECC-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āφāϛ⧇āĨ¤


Actionable Clinical Plan

Step 1: āϰ⧋āĻ—ā§€āϰ vaginal symptoms āĻ“ urinary symptoms āφāϞāĻžāĻĻāĻžāĻ­āĻžāĻŦ⧇ history āύāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 2: Pregnancy possibility, medication allergy āĻāĻŦāĻ‚ current medication history āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 3: āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ vulval āĻ“ speculum examination āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 4: Urinary symptoms āĻĨāĻžāĻ•āϞ⧇ Urine R/E Âą Culture āĻāĻŦāĻ‚ vaginal symptoms āĻ…āύ⧁āϝāĻžā§Ÿā§€ vaginal testing āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 5: Azithromycin āĻ“ Ornidazole āĻĻ⧇āĻ“ā§ŸāĻžāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āĻāĻŦāĻ‚ duration āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 6: āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻĨāĻžāĻ•āĻžā§Ÿ neurological assessment āĻ•āϰāϤ⧇ āĻšāĻŦ⧇, āĻŦāĻŋāĻļ⧇āώāϤ prolonged Ornidazole āĻŦāĻŋāĻŦ⧇āϚāύāĻžāϰ āφāϗ⧇āĨ¤

Step 7: āĻĒā§‚āĻ°ā§āĻŦ⧇āϰ D&C/ECC-āĻāϰ procedure note āĻ“ histopathology report āĻĒāĻ°ā§āϝāĻžāϞ⧋āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 8: āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ diagnosis āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇ guideline-based targeted treatment āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 9: Follow-up-āĻ symptoms, examination findings āĻāĻŦāĻ‚ treatment response documented āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤


Reference List

A. Medical Textbooks

  1. Harrison's Principles of Internal Medicine. 21st edition. McGraw Hill. Relevant sections: Urinary Tract Infections, Peripheral Neuropathy and Clinical Evaluation of Dysuria.
  2. Williams Gynecology. 4th edition. McGraw Hill. Relevant chapters: Lower Genital Tract Infections, Cervical Disorders and Gynecologic Examination.
  3. Berek & Novak's Gynecology. 16th edition. Wolters Kluwer. Relevant sections: Vulvovaginal Infections and Cervical Disease.
  4. Dutta's Textbook of Gynecology. 8th edition. Jaypee Brothers. Relevant chapters: Vaginal Discharge and Cervical Disorders.
  5. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th edition. McGraw Hill. Relevant chapters: Antibacterial Drugs, Antiprotozoal Drugs and Sedative-Hypnotics.
  6. Katzung's Basic & Clinical Pharmacology. 16th edition. McGraw Hill. Relevant chapters: Benzodiazepines, Macrolides, Nitroimidazoles and Vitamins.

Textbook page numbers have not been independently verified and are not supplied.

B. Clinical Guidelines

  1. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021. Vulvovaginal symptoms, Bacterial Vaginosis, Trichomoniasis, Candidiasis and Cervicitis.
  2. NICE Guideline NG109. Urinary Tract Infection (Lower): Antimicrobial Prescribing. Published 2018.
  3. MedEx Bangladesh. Verified monographs of Xionil 3 mg, Zithrox 500 mg, Riboflavine 5 mg and Ornil 500 mg.

C. Peer-Reviewed Journals With DOI

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports. 2021;70(4):1–187. DOI: 10.15585/mmwr.rr7004a1.
  2. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does This Woman Have an Acute Uncomplicated Urinary Tract Infection? JAMA. 2002;287(20):2701–2710. DOI: 10.1001/jama.287.20.2701.

LIPU MED — Author Information

Author Name: Md.Rafiqul Islam Lipu

Date: Thursday, 15 October 2026

Time: 9:16 PM — Bangladesh Standard Time (UTC+06:00)

Website: raiyyantahsan.com

Final Prescription-Ready Provisional Dx:

Suspected Vulvovaginitis with Vaginal/Urethral Burning; R/O BV, Trichomoniasis, Cervicitis and Acute Cystitis; Associated Hand Paresthesia; H/O Cervical Erosion and D&C/ECC.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ“ āϝ⧋āύāĻŋ-āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϤ⧇ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž; āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϞ āĻ­ā§āϝāĻžāϜāĻžāχāύ⧋āϏāĻŋāϏ, āĻŸā§āϰāĻžāχāϕ⧋āĻŽā§‹āύāĻŋ⧟āĻžāϏāĻŋāϏ, āϜāϰāĻžā§Ÿā§āĻŽā§āĻ– āĻ“ āĻŽā§‚āĻ¤ā§āϰāĻĨāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āϝāĻžāϚāĻžāχ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ; āϏāĻ™ā§āϗ⧇ āĻšāĻžāϤ⧇ āĻ…āĻŦāĻļāĻ­āĻžāĻŦ āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇ āϜāϰāĻžā§Ÿā§āĻŽā§āϖ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top